Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Simon J Draper

Showing results (61-70 of 165) with videos related to

Pageof 17
Sort By:
EMBO Reports|February 17, 2026
Structures of proteinase 3 and the CD177 receptor complex reveal a major autoantibody epitopeCéline Zheng-Gérard, Jana Joha, Maria Carrasquero, et al.
Toxicon: X|September 16, 2024
Plug and play virus-like particles for the generation of anti-toxin antibodiesRebecca J Edge, Amy E Marriott, Emma L Stars, et al.
Mbio|September 9, 2020
The Structure of the Cysteine-Rich Domain of Plasmodium falciparum P113 Identifies the Location of the RH5 Binding SiteIvan Campeotto, Francis Galaway, Shahid Mehmood, et al.
Infection and Immunity|September 26, 2024
Synergistic blockade of TIGIT and PD-L1 increases type-1 inflammation and improves parasite control during murine blood-stage <i>Plasmodium yoelii</i> non-lethal infectionRebecca S Dookie, Ana Villegas-Mendez, Antonn Cheeseman, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 5, 2011
The requirement for potent adjuvants to enhance the immunogenicity and protective efficacy of protein vaccines can be overcome by prior immunization with a recombinant adenovirusSimone C de Cassan, Emily K Forbes, Alexander D Douglas, et al.
Plos One|June 24, 2011
Transgene optimization, immunogenicity and in vitro efficacy of viral vectored vaccines expressing two alleles of Plasmodium falciparum AMA1Sumi Biswas, Matthew D J Dicks, Carole A Long, et al.
Plos One|September 18, 2012
T cell responses induced by adenoviral vectored vaccines can be adjuvanted by fusion of antigen to the oligomerization domain of C4b-binding proteinEmily K Forbes, Simone C de Cassan, David Llewellyn, et al.
Molecular & Cellular Proteomics : MCP|November 2, 2017
Functional Characterization and Comparison of <i>Plasmodium falciparum</i> Proteins as Targets of Transmission-blocking AntibodiesDaria Nikolaeva, Joseph J Illingworth, Kazutoyo Miura, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 8, 2013
Assessment of immune interference, antagonism, and diversion following human immunization with biallelic blood-stage malaria viral-vectored vaccines and controlled malaria infectionSean C Elias, Katharine A Collins, Fenella D Halstead, et al.
Plos Pathogens|September 15, 2023
The dual action of human antibodies specific to Plasmodium falciparum PfRH5 and PfCyRPA: Blocking invasion and inactivating extracellular merozoitesGreta E Weiss, Robert J Ragotte, Doris Quinkert, et al.
Pageof 17

Showing results (61-70 of 165) with videos related to

Sort By:
Pageof 17
EMBO Reports|February 17, 2026
Structures of proteinase 3 and the CD177 receptor complex reveal a major autoantibody epitopeCéline Zheng-Gérard, Jana Joha, Maria Carrasquero, et al.
Toxicon: X|September 16, 2024
Plug and play virus-like particles for the generation of anti-toxin antibodiesRebecca J Edge, Amy E Marriott, Emma L Stars, et al.
Mbio|September 9, 2020
The Structure of the Cysteine-Rich Domain of Plasmodium falciparum P113 Identifies the Location of the RH5 Binding SiteIvan Campeotto, Francis Galaway, Shahid Mehmood, et al.
Infection and Immunity|September 26, 2024
Synergistic blockade of TIGIT and PD-L1 increases type-1 inflammation and improves parasite control during murine blood-stage <i>Plasmodium yoelii</i> non-lethal infectionRebecca S Dookie, Ana Villegas-Mendez, Antonn Cheeseman, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 5, 2011
The requirement for potent adjuvants to enhance the immunogenicity and protective efficacy of protein vaccines can be overcome by prior immunization with a recombinant adenovirusSimone C de Cassan, Emily K Forbes, Alexander D Douglas, et al.
Plos One|June 24, 2011
Transgene optimization, immunogenicity and in vitro efficacy of viral vectored vaccines expressing two alleles of Plasmodium falciparum AMA1Sumi Biswas, Matthew D J Dicks, Carole A Long, et al.
Plos One|September 18, 2012
T cell responses induced by adenoviral vectored vaccines can be adjuvanted by fusion of antigen to the oligomerization domain of C4b-binding proteinEmily K Forbes, Simone C de Cassan, David Llewellyn, et al.
Molecular & Cellular Proteomics : MCP|November 2, 2017
Functional Characterization and Comparison of <i>Plasmodium falciparum</i> Proteins as Targets of Transmission-blocking AntibodiesDaria Nikolaeva, Joseph J Illingworth, Kazutoyo Miura, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 8, 2013
Assessment of immune interference, antagonism, and diversion following human immunization with biallelic blood-stage malaria viral-vectored vaccines and controlled malaria infectionSean C Elias, Katharine A Collins, Fenella D Halstead, et al.
Plos Pathogens|September 15, 2023
The dual action of human antibodies specific to Plasmodium falciparum PfRH5 and PfCyRPA: Blocking invasion and inactivating extracellular merozoitesGreta E Weiss, Robert J Ragotte, Doris Quinkert, et al.
Pageof 17